INBX - Inhibrx Biosciences, Inc.
IEX Last Trade
15.16
0.240 1.583%
Share volume: 944
Last Updated: Fri 27 Dec 2024 08:30:38 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$14.92
0.24
1.61%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-08 | 2022-11-07 | 2023-03-06 | 2023-05-08 | 2023-08-07 | 2023-11-09 | 2024-02-28 | 2024-05-09 | |
| Cash flow financing | 60.162 M | 506.000 K | 158.659 M | 356.000 K | 854.000 K | 199.891 M | 860.000 K | 38.728 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -26.922 M | -30.838 M | -30.600 M | -39.944 M | -42.299 M | -54.245 M | -56.821 M | -63.050 M | |
| Net income | -37.732 M | -35.325 M | -40.915 M | -48.916 M | -47.052 M | -51.789 M | -93.604 M | -78.710 M | |
| Depreciation | 307.000 K | 309.000 K | 302.000 K | 295.000 K | 294.000 K | 304.000 K | 298.000 K | 360.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 284.000 K | 315.000 K | 257.000 K | 304.000 K | 327.000 K | 331.000 K | 778.000 K | 3.038 M | |
| Investing Cashflow | -322.000 K | 20.000 K | -267.000 K | -23.000 K | -317.000 K | -811.000 K | -3.442 M | -1.119 M | |
| Net Borrowings | -5.643 M | 22.849 M | -73.134 M | -35.621 M | 5.618 M | -153.588 M | -84.439 M | -60.612 M | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -322.000 K | 20.000 K | -267.000 K | -23.000 K | -317.000 K | -811.000 K | -3.442 M | -1.119 M | |
| Cash Change | 176.385 M | 146.073 M | 273.865 M | 234.254 M | 192.492 M | 337.327 M | 277.924 M | 252.483 M |